EODData

OTCBB, KSPHF: Kissei Pharmaceutical Co. Ltd

20 Oct 2025
LAST:

25.10

CHANGE:
 5.18
OPEN:
25.10
HIGH:
25.10
ASK:
0.00
VOLUME:
500
CHG(%):
17.11
PREV:
30.28
LOW:
25.10
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

COMPANY PROFILE

Name:Kissei Pharmaceutical Co. Ltd
About:Kissei Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia. Its products in pipeline include CG0070, which is in Phase III clinical trial to treat non-muscle-invasive bladder cancer; Linzagolix, which is in Phase III clinical trial for the treatment of uterine fibroids and endometriosis; KDT-3594, which is in Phase II clinical trial to treat Parkinson's disease; KSP-0243 that is in Phase II clinical trial to treat Ulcerative colitis; and Difelikefalin, which is in Phase III clinical trial to treat uremic pruritus in dialysis patients. The company is also developing Silodosin for dysuria associated with benign prostatic hyperplasia; and Fostamatinib for tyrosine kinase inhibitor. In addition, it develops and sells protein controlled and energy supply foods; and purchases and sells related materials, as well as offers system development and information processing, construction contracting, facility and equipment management, and information gathering and development support services. Further, the company engages in the information equipment rentals; insurance agency business; manufactures and sells noodles; and undertakes construction of factories, research institutes, offices, etc., as well as computer system design and development, and cloud services. The company was formerly known as Kissei Yakuhin Kogyo Co., Ltd. and changed its name to Kissei Pharmaceutical Co., Ltd. in October 1964. The company was incorporated in 1946 and is headquartered in Matsumoto, Japan.
Sector:Healthcare
Address:19-48, Yoshino, Matsumoto, Japan, 399-8710
Website:https://www.kissei.co.jp
CIK:0001532923
FIGI:BBG000DQSMT7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:16.37 
Price to Sales:0.01 
Price to Book:0.90 
DivYield:0.03 
Div/Share:100.00 
Revenue:89.357B 
EBITDA:10.43B 
Shares:41.44M 
Market Cap:1.04B 

TECHNICAL INDICATORS

MA5:25.923.3%
Week High:25.100.0%
Week Low:25.100.0%